NCT03028038View on ClinicalTrials.gov

Using Platelet Rich Plasma in Reducing Alveolar Bone Resorption During Rapid Maxillary Expansion

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

July 15, 2018

Conditions
Bone Resorption
Interventions
DRUG

Platelet Rich Plasma

"Platelet Rich Plasma (PRP) will be injected beneath the buccal periosteal of the first molar and premolar in one mouth side with a split-mouth design before the beginning of Rapid Maxillary Expansion and after 7 days of it.~High resolution cone beam computed tomography (CBCT) will be taken before treatment and after 3 months when the Hyrax is removed."

DRUG

No Platelet Rich Plasma

"No Platelet Rich Plasma (PRP) will be injected in the other mouth side with a split-mouth design during Rapid Maxillary Expansion.~High resolution cone beam computed tomography (CBCT) will be taken before treatment and after 3 months when the Hyrax is removed."

Trial Locations (1)

Unknown

Damascus University, Damascus

All Listed Sponsors
lead

Damascus University

OTHER

NCT03028038 - Using Platelet Rich Plasma in Reducing Alveolar Bone Resorption During Rapid Maxillary Expansion | Biotech Hunter | Biotech Hunter